Will Black Diamond Therapeutics (NASDAQ:BDTX) Spend Its Cash Wisely?

By Yahoo! Finance | Jul 2, 2024 at 06:52 AM EST

While some unprofitable businesses eventually find success, others fail. Black Diamond Therapeutics had a 20-month cash runway in March 2024 with $115m in cash and $68m cash burn. Shareholders should monitor its cash burn and consider potential dilution risks.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.